GLATFELTER CORP (GLT)

US3773201062 - Common Stock

1.65  +0.03 (+1.85%)

After market: 1.65 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GLT. GLT was compared to 9 industry peers in the Paper & Forest Products industry. GLT may be in some trouble as it scores bad on both profitability and health. GLT does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year GLT has reported negative net income.
GLT had a negative operating cash flow in the past year.
In multiple years GLT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: GLT reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -6.05%, GLT is doing worse than 66.67% of the companies in the same industry.
GLT has a worse Return On Equity (-41.11%) than 77.78% of its industry peers.
GLT has a Return On Invested Capital of 0.81%. This is comparable to the rest of the industry: GLT outperforms 44.44% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GLT is significantly below the industry average of 7.05%.
Industry RankSector Rank
ROA -6.05%
ROE -41.11%
ROIC 0.81%
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%

1.3 Margins

GLT has a Operating Margin (0.97%) which is in line with its industry peers.
GLT's Operating Margin has declined in the last couple of years.
GLT has a Gross Margin (9.59%) which is comparable to the rest of the industry.
GLT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.97%
PM (TTM) N/A
GM 9.59%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GLT is destroying value.
Compared to 1 year ago, GLT has more shares outstanding
GLT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for GLT is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.57, we must say that GLT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.57, GLT is in line with its industry, outperforming 55.56% of the companies in the same industry.
GLT has a Debt/Equity ratio of 3.92. This is a high value indicating a heavy dependency on external financing.
GLT has a Debt to Equity ratio of 3.92. This is amonst the worse of the industry: GLT underperforms 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.92
Debt/FCF N/A
Altman-Z 1.57
ROIC/WACC0.13
WACC6.31%

2.3 Liquidity

A Current Ratio of 2.31 indicates that GLT has no problem at all paying its short term obligations.
GLT has a Current ratio (2.31) which is comparable to the rest of the industry.
GLT has a Quick Ratio of 1.13. This is a normal value and indicates that GLT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of GLT (1.13) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.13

1

3. Growth

3.1 Past

The earnings per share for GLT have decreased strongly by -144.19% in the last year.
The Revenue for GLT has decreased by -10.31% in the past year. This is quite bad
Measured over the past years, GLT shows a quite strong growth in Revenue. The Revenue has been growing by 9.85% on average per year.
EPS 1Y (TTM)-144.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-153.85%
Revenue 1Y (TTM)-10.31%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%-13.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GLT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GLT indicates a slightly more expensive valuation: GLT is more expensive than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.95

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GLT!.
Industry RankSector Rank
Dividend Yield N/A

GLATFELTER CORP

NYSE:GLT (6/20/2024, 5:30:00 PM)

After market: 1.65 0 (0%)

1.65

+0.03 (+1.85%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap74.66M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.05%
ROE -41.11%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.97%
PM (TTM) N/A
GM 9.59%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 3.92
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.31
Quick Ratio 1.13
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-144.19%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-10.31%
Revenue growth 3Y14.77%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y